依普利酮医保是否可以报销？

(eplerenone) is a new generation of selective aldosterone antagonist developed by Pfizer/Pharmacia under the trade name Inspra. It is used for the treatment of hypertension, heart failure and myocardial infarction. It has definite efficacy in the treatment of hypertension, heart failure and myocardial infarction. Eplerenone (eplerenone) was first launched in the United States in 2002 for the treatment of hypertension, heart failure and myocardial infarction. Its outstanding advantage is that for severe hypertension that cannot be controlled by a combination of multiple antihypertensive drugs, the addition of eplerenone can significantly reduce blood pressure, especially the decrease in systolic blood pressure is more significant. For patients with severe heart failure and myocardial infarction, eplerenone combined with angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers can improve quality of life and reduce mortality. The clinical advantages of eplerenone: 1. For the treatment of heart failure after acute myocardial infarction, combined use with standard treatment drugs can reduce the total mortality rate in the treatment group by 15% (P=0.008); 2. Eplerenone is as effective as enalapril in reversing left ventricular hypertrophy and hypertension, with fewer cough side effects, and the combined application effect is more obvious; 3. Few adverse reactions, except for the adverse reaction of elevated blood potassium, other adverse reactions are no different from the placebo group; 4. There are almost no sex hormone-related side effects of spironolactone.

So, will eplerenone be reimbursed by medical insurance? It is understood that eplerenone has not yet been approved for marketing in China, so it does not support medical insurance reimbursement. The price of eplerenone sold abroad is relatively expensive, and ordinary patients cannot afford it for a long time. The good news is that a box of 50 mg × 100 tablets of eplerenone from India's Lupine Pharmaceuticals sells for about $500, which is currently the most cost-effective (eplerenone) version. Since exchange rates fluctuate and prices are not fixed, please consult Medical Travel for specific prices.